Fagron (XAMS:FAGR) YoY EBITDA Growth : -1.84% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Fagron YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Fagron's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -1.84%.

Fagron's EBITDA per Share for the six months ended in Dec. 2023 was €0.85.

Fagron YoY EBITDA Growth Historical Data

The historical data trend for Fagron's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron YoY EBITDA Growth Chart

Fagron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

29.48

4.59

-1.10

16.20

3.26

Fagron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															8.82	20.36	11.97	9.48	-1.84

Fagron YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Fagron's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(1.837	-	1.779)	/	\| 1.779 \|
=	3.26 %

Fagron's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.854	-	0.87)	/	\| 0.87 \|
=	-1.84 %

Fagron YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Fagron's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Fagron (XAMS:FAGR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (XAMS:FAGR) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

ARSUF:USA FAGRb:UK 0HNZ:UK 4A5:Germany FAGR:Belgium

Address

Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB

Website

https://www.fagron.com

Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America and Fagron Latin America. Majority of its revenue comes from Fagron EMEA.

Fagron (XAMS:FAGR) Headlines

No Headlines